Joel Greenblatt Axsome Therapeutics, Inc. Transaction History

Gotham Asset Management, LLC

  • $9.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$41.2 - $101.31 $102,794 - $252,768
-2,495 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$16.71 - $106.24 $41,691 - $265,068
2,495 New
2,495 $258,000
Q3 2019

Nov 14, 2019
SELL
$20.24 - $29.16 $225,837 - $325,367
-11,158 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$13.46 - $25.75 $150,186 - $287,318
11,158 New
11,158 $287,000

Others Institutions Holding AXSM

# of Institutions
326
Shares Held
37.7M
Call Options Held
912K
Put Options Held
855K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.99B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email